Andromachi Vryonidou

Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome

Andromachi Vryonidou, Anna Tavridou, Thomais Terzi et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 171 citations · Full text

Medicine, Endocrinology, Gynecology +15

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome

Evangeline Vassilatou, Sophia Lafoyianni, Andromachi Vryonidou et al. · Human Reproduction · 2009 · 144 citations

Medicine, Endocrinology, Gynecology +17

Th1 and Th2 Serum Cytokine Profiles Characterize Patients with Hashimoto’s Thyroiditis (Th1) and Graves’ Disease (Th2)

C. Phenekos, Andromachi Vryonidou, Angelos D. Gritzapis et al. · NeuroImmunoModulation · 2004 · 136 citations

Life Sciences, Endocrinology, Immunology +11

Hormonal activity of adrenal incidentalomas: results from a long‐term follow‐up study

Evangeline Vassilatou, Andromachi Vryonidou, Semina Michalopoulou et al. · Clinical Endocrinology · 2008 · 112 citations

Medicine, Endocrinology, Pathology +17

Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries.

George Mastorakos, Chrisoula D. Scopa, Andromachi Vryonidou et al. · The Journal of Clinical Endocrinology & Metabolism · 1994 · 78 citations

Medicine, Endocrinology, Gynecology +9